Rifabutin

Mycobutin, capsules 150 mg

Capsule, hardNetherlandsAuthorisedAuthorised 17 Jul 1995

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Rifabutin

Mycobutin, capsules 150 mg

Capsule, hardNetherlandsAuthorisedAuthorised 17 Jul 1995

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Taiwan · 膠囊劑 · 微確藥品有限公司

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim · Added 8 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Rifabutin
Dosage form: Capsule, hard
Route: Oraal gebruik
Register: Netherlands (CBG-MEB)
Status: Authorised
Status in the register: Ingeschreven
Authorised: 17 Jul 1995
Registration: 16740
Marketing authorisation holder: Pfizer B.V.
ATC code: J04AB04
Group: Anti-infectives for systemic use
Procedure: National (RVG)
Supply: Uitsluitend recept